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Available online 25 June 2016Background: Auditory hallucinations are experienced by 60–80% of all patients diagnosed with a schizophrenia
spectrum disorder. However, in this patient group, the prevalence of hallucinations in multiple sensory modali-
ties, i.e. multimodal hallucinations (MMHs), is unknown.
Aims: To assess the prevalence ofMMHs inpatients diagnosedwith a schizophrenia spectrumdisorder, datawere
analyzed from 750 patients who participated in the Dutch Genetic Risk and Outcome of Psychosis (GROUP)
study.
Method:Wedrewon the section of the CASH (Comprehensive Assessment of Symptoms andHistory) that probes
into the lifetime presence of auditory, visual, somatic/tactile, and olfactory hallucinations.
Results: A lifetime prevalence of 80%was found in this group for hallucinations in any of thesemodalities.Within
thewhole group, 27% of the participants reported unimodal hallucinations and 53%MMHs. There were no signif-
icant differences in prevalence rate for Dutch versus migrant participants fromMorocco, Turkey, Surinam or the
(former) Dutch Antilles.
Conclusion: We conclude that MMHs, rather than auditory hallucinations, are the most frequent perceptual
symptom of patients diagnosed with a schizophrenia spectrum disorder. Our data also suggest that hallucina-
tions experienced in a single sensory modality (notably auditory ones) stochastically increase the risk for more
sensory modalities to join in. We recommend that future studies take into account all 14 sensory modalities in
which hallucinations can be experienced. For this we provide a classiﬁcation of MMHs that allows characteriza-
tion of their serial versus simultaneous occurrence and their congruent versus incongruent nature.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Compound hallucination
Panoramic hallucination
Polymodal hallucination
Multimodal hallucination
Stochastic process
Unimodal hallucination1. Introduction
Of all patients diagnosed with a schizophrenia spectrum disorder,
60–80% experience auditory hallucinations (Waters et al., 2014) and a
smaller proportion visual or other unimodal hallucinations. However,
in this patient group, little is known about hallucinations in multiplete, Kiwistraat 43, 2552 DH The
88 3584195.
. This is an open access article undersensory modalities, also known as multimodal hallucinations (MMHs).
Below, we will explain that the term multimodal hallucination is used
for both serial and simultaneous hallucinations occurring in different
sensorymodalities. As noted in a review (Waters et al., 2014) the nature
of the relationship between hallucinations of different sensory modali-
ties has hardly been examined. Although this situation is not unique
for schizophrenia spectrum disorders (Waters et al., 2014), some stud-
ies indicate that the prevalence ofmultimodal hallucinationsmay be se-
verely underestimated in this group (Goodwin et al., 1971)while others
indicate that the presence of MMHs may be indicative of an underlyingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Overviewof studies describingmultimodal hallucinations in the context of various psychi-
atric and somatic conditions.
Diagnosis Study
Sensory
modalities
Serially/simultaneously
occurring
hallucinations
Psychiatric disorders
Schizophrenia Goodwin
et al.
(1971)
Auditory and
visual
Serially and
simultaneously
Late onset
schizophrenia
Hussein
et al.
(2012)
Not mentioned Not mentioned
Late onset
schizophrenia
Pearlson
et al.
(1989)
Not mentioned Not mentioned
Late onset
schizophrenia
Eissa et
al. (2013)
Not mentioned Not mentioned
Schizophrenia in Saudi
Arabia
Zarroug
(1975)
Auditory, visual,
tactile
Simultaneously
Schizophrenia in Kenya Ndetei
and
Singh
(1983)
Not mentioned Not mentioned
Borderline personality
disorder
Yee et al.
(2005)
Visual and
olfactory
Not mentioned
Neurological disorders
Temporal lobe epilepsy Penﬁeld
and Perot
(1963)
Auditory and
visual, sometimes
tactile and
olfactory
Serially and
simultaneously
Narcolepsy Szűcs et
al. (2003)
Hypnagogic
hallucinations;
tactile and visual
Not mentioned
Right temporo-basal
tumor
Güzelcan
et al.
(2008)
Visual and tactile Simultaneously
Right thalamic stroke Mollet et
al. (2007)
Auditory and
visual
Simultaneously
Cerebrovascular
accident presenting
with peduncular
hallucinosis
Dogan et
al. (2013)
Auditory and
visual
Simultaneously
Charles Bonnet
syndrome
Alroe and
McIntyre
(1983)
Visual and
olfactory
Simultaneously
Delirium tremens Deahl
(1987)
Auditory and
visual
Simultaneously
Infectious disease
Peduncular hallucinosis Vita et al.
(2008)
Auditory and
visual
Simultaneously
Neuropsychiatry
Lewy body disease Aarsland
et al.
(2001)
Auditory and
visual
Not mentioned
Substance abuse
Ketamine use Lim
(2003)
Auditory and
olfactory
Not mentioned
Alcohol hallucinosis Bhat et al.
(2012)
Auditory, visual,
and tactile
Not mentioned
Drug and alcohol abuse Scher and
Neppe
(1989)
Auditory, visual,
and gustatory
Not mentioned
Iatrogenic cause
Carbamazepine use Benatar
et al.
(2000)
Auditory, visual,
and tactile
Auditory and visual
simultaneously
494 A. Lim et al. / Schizophrenia Research 176 (2016) 493–499organic etiology (Roberts, 1984; Albert, 1987), or, in children and ado-
lescents, of a more severe expression of schizophrenia (David et al.,
2011; Jardri et al., 2014; Cachia et al., 2015).
MMHs are also known as polymodal hallucinations, polysensual hal-
lucinations, polysensory hallucinations, polysensorial hallucinations,intersensorial hallucinations, and fantastic hallucinations (Blom,
2010). In the literature these terms tend to be used interchangeably;
however, in some cases they refer to hallucinations experienced in var-
ious sensory modalities simultaneously, while in others they refer to
those experienced serially (Chesterman and Boast, 1994).
Whatever the reason, the literature onMMHs is scarce. Themost ex-
tensive review to date was published by Chesterman and Boast in 1994
and the most recent review prior to that is a chapter in Specht's 1914
German textbookWahrnehmung und Halluzination (Specht, 1914). Dur-
ing the 80-year intervening period, as well as during the 20 years since
the publication of Chesterman and Boast, MMHs have mainly been ref-
erenced in case reports (Alroe and McIntyre, 1983; Scher and Neppe,
1989; Benatar et al., 2000; Lim, 2003; Szűcs et al., 2003; Yee et al.,
2005; Mollet et al., 2007; Güzelcan et al., 2008; Vita et al., 2008; Bhat
et al., 2012; Dogan et al., 2013), in the ﬁeld of neuropsychiatry
(Aarsland et al., 2001), and in studies in theﬁeld of transcultural psychi-
atry (Zarroug, 1975; Al-Issa, 1977; Ndetei and Singh, 1983; Kent and
Wahass, 1996; Blom et al., 2010; Johns et al., 2002; Bauer et al., 2011;
Hussein et al., 2012; Larøi et al., 2014; Lim et al., 2015; Luhrmann et
al., 2015), see Table 1. Even classic authors such as Parish (1894),
Bleuler (1911) and Jaspers (1965), whowrote extensively on hallucina-
tions in various sensory modalities, treated the subject only cursorily.
Table 1 provides an overview of studies we retrieved on MMHs experi-
enced in the context of psychiatric and somatic conditions.
To further our understanding of MMHs and their prevalence rate in
patients diagnosed with a schizophrenia spectrum disorder, we drew
on data from the Genetic Risk and Outcome of Psychosis (GROUP) study,
conducted in the Netherlands from 2004 through 2013 (Korver et al.,
2012). Below, we present data from this study on hallucinations in var-
ious sensorymodalities, address various conceptual issues pertaining to
MMHs, and propose a classiﬁcation of this neglected group of phenom-
ena to serve both clinical and research purposes.2. Method
2.1. Study design
A longitudinal cohort study on gene-environment vulnerability and
resilience in patients diagnosedwith a schizophrenia spectrumdisorder
(DSM IV classiﬁcation), their unaffected family members, and non-re-
lated controls, was performed by the GROUP project. Individuals were
recruited to elucidate etiological and pathogenetic factors inﬂuencing
the onset and course of psychotic disorders. The study was conducted
in the Netherlands within a consortium of four university psychiatric
centers and 30 of their afﬁliated mental healthcare institutions
(Korver et al., 2012). One of the instruments used was the CASH (Com-
prehensive Assessment of Symptoms and History) (Andreasen et al., 1992)
which contains sections on the lifetime presence and the present state
(i.e., past month) of hallucinations experienced in the auditory, visual,
somatic/tactile, and olfactory modalities.2.2. Subjects
Ethnicity was determined in the GROUP project by country of birth
of grandfather and grandmother on the fathers' and mothers' sides.
Thus, a subject was considered to be of Dutch ethnicity when three or
more grandparents were born in the Netherlands. Mutatis mutandis,
this rule applied to all ethnicities. Whenever less than three grandpar-
ents were born in the same country, the subject was said to have a
mixed ethnicity. We selected all patients who had completed the
study's baselinemeasurements and excluded thosewhose datawere in-
complete. Outcomemeasures were (1) the number of patients who had
ever experienced any of the aforementioned types of hallucination, (2)
the types of hallucination, and (3) their distribution.
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495A. Lim et al. / Schizophrenia Research 176 (2016) 493–4992.3. Data analysis
Analyses comprised a calculation of odds ratios (ORs) from cross
tabulations and multivariate logistic regression. A conﬁdence interval
(CI) of 95% was considered to indicate statistical signiﬁcance for the
ORs. Akaike's Information Criterion (AIC) (Akaike, 1974) was used for
model-selection purposes regarding the logistic regression. For the sta-
tistical analyses, SPSS version 23 and Excel 2010 were used.
3. Results
For the present study, complete data on hallucinations in patients di-
agnosed with a schizophrenia spectrum disorder were available from
750 patients who had participated in the GROUP study. Their mean
age was 27 (range 15–57, SD 7.424) years, and 77.3% were men. Of all
these patients, 603 (80%) had experienced one ormore types of halluci-
nation throughout their lives. Hallucinations in a single sensory modal-
ity were reported by 204 of them, yielding a lifetime prevalence for
unimodal hallucinations of 27%, whereas hallucinations in two or
more sensory modalities were reported by 399 patients, yielding a life-
time prevalence for MMHs of 53% in the total group. Twenty-nine per-
cent of the patients experienced hallucinations in two sensory
modalities, 17% experienced them in three sensory modalities, and 8%
experienced hallucinations in four sensory modalities. Table 2 shows
that auditory hallucinations were the most prevalent type of hallucina-
tion in the unimodal-hallucination group (68%) as well as in the MMH
group (88%), followed by visual, somatic/tactile, and olfactory hallucina-
tions. Fig. 1 presents the distribution of the various types of hallucination.
Present-state scores on hallucinations showed that 285 patients
(38%) experienced one or more hallucinations during the month pre-
ceding the CASH interview. Hallucinations in a single sensory modality
during the last month were reported by 162 patients (22%), whereas
hallucinations in two or more sensory modalities were reported by
123 patients, yielding a present-state (i.e., one-month) prevalence for
MMHs of 16% (Table 2). Fig. 2 displays the distribution of the present-
state hallucinations. The lifetime ORs for MMHs in two sensory modal-
ities for patients who already experienced unimodal hallucinations
were, respectively, 2.312 [1.454–3.676; from auditory]; 11.320 [7.121–
17.997; from visual]; 4.311 [2.447–7.594; from somatic/tactile]; and
3.664 [1.759–7.632; from olfactory]. The ORs forMMHs in three sensory
modalities in patients who already experienced bimodal hallucinations
were also increased, respectively 2.715 [1.640–4.494; from auditory-vi-
sual]; 7.013 [4.275–11.507; from auditory-somatic]; 11.111 [5.83167–
21.170; from auditory-olfactory]; 15.911 [8.579–29.507; from visual-
somatic]; 9.590 [4.934–18.640; from visual-olfactory]; and 7.905
[3.330–18.769; from somatic-olfactory].
We also calculatedORs for the lifetimeprevalence ofMMHs in Dutch
patients versus the combined groups of patients from Morocco (n =
23), Turkey (n= 15), Surinam (n= 18), and the (former) Dutch Antil-
les (n = 4), but found no signiﬁcant differences (OR 0.768, [0.433–
1.363]) between these latter groups and the Dutch group.
4. Discussion
Our ﬁndings indicate that the lifetime prevalence of MMHs in pa-
tients diagnosed with a schizophrenia spectrum disorder is almost
twice as high as that of all unimodal hallucinations taken together
(53% vs. 27%). As unimodal auditory hallucinations (notably of the ver-
bal type) are traditionally considered the most prevalent type of hallu-
cination in this patient group, this raises the question why this high
prevalence of MMHs has rarely been reported. Or, to rephrase the ques-
tion, why studies that did ﬁnd elevated prevalence rates for MMHs are
rarely cited. For example, Table 1 lists several studies that, retrospec-
tively, appear to have anticipated our ﬁndings. In the general popula-
tion, probably the most extensive prevalence study of MMHs is the
19th-century Census of Hallucinations, carried out by the Society for
Fig. 1. Schematic diagram showing the lifetime distribution of unimodal and multimodal hallucinations among 603 patients from a total of 750 patients diagnosed with a schizophrenia
spectrum disorder.
496 A. Lim et al. / Schizophrenia Research 176 (2016) 493–499Psychical Research (SPR). This study aimed to chart the prevalence of
death-related visions and, to that end, collected data from 27,329 indi-
viduals in the UK, the USA, Germany, and France, among whom
11.96% had experienced one or more hallucinatory episodes (Parish,
1894; Sidgwick et al., 1894). Within the hallucinating group, MMHs in
the auditory, visual and tactile modalities were reported by 12.3% of
all hallucinating individuals. In a study by Goodwin et al. (1971),
among 117 patients diagnosed variouslywith affective disorder, schizo-
phrenia, alcoholism, organic brain syndrome, and hysteria, about 75%
experienced hallucinations in two or more sensory modalities. Among
the few prevalence studies of MMHs among patients diagnosed with a
schizophrenia spectrum disorder, a relatively large study stands out
(Mueser et al., 1990), describing 117 patients with a DSM-III-R diagno-
sis of schizophrenia or schizoaffective disorder, among whom auditory
hallucinationswere themost common, followed by visual, and then tac-
tile, olfactory, and gustatory hallucinations. Interestingly, the authors
also found that hallucinations in two sensory modalities were experi-
enced more frequently in their group than isolated auditory hallucina-
tions. A retrospective study comparing adults with early-onset
schizophrenia and with late-onset schizophrenia, as well as elderly pa-
tientswith early-onset schizophrenia, found that the number of types of
hallucination for the late-onset group was signiﬁcantly higher than in
the early-onset groups (Pearlson et al., 1989). In a smaller study con-
ducted in theMiddle East, patients with late-onset schizophrenia expe-
rienced MMHs more often than those with early-onset schizophrenia;
however, their distribution and prevalence rate were not extensively
discussed (Eissa et al., 2013). In another small study from the Middle
East, elderly patients with late-onset schizophrenia experienced
MMHs more often than psychotic patients who were not diagnosed
with schizophrenia (Hussein et al., 2012). Zarroug (1975) examined69 Saudi-Arabian patients diagnosed with schizophrenia and found
that 51% experienced MMHs. In a cross-cultural comparative study,
Ndetei and Vadher (1984) found that MMHs in the auditory and visual
sensory modalities were more prevalent in African, West-Indian, and
Asian patients than in British patients, most of whom experienced
unimodal auditory hallucinations.
Our analysis of the GROUP data largely conﬁrms the above-men-
tioned prevalence data for the various types of unimodal hallucination
in patients diagnosed with a schizophrenia spectrum disorder
(Goodwin et al., 1971; Mueser et al., 1990). A reason why other studies
failed to replicate the ﬁndings of these authors may be that they did not
broaden their scope to include other types of hallucination (Waters et
al., 2014) and that the prevalence of MMHs has therefore been system-
atically underestimated. Secondly, the presence of hallucinations in
other sensory modalities has traditionally led to non-psychiatric diag-
noses (Waters et al., 2014) such as organic or neurological ones
(Roberts, 1984; Albert, 1987). Another explanation may be that the
CASH, apart from providing a systematic screening of hallucinations in
four sensory modalities, has the advantage of describing their present-
state occurrence as well as their lifetime presence. As verbal auditory
hallucinations experienced by psychotic patients are probablymore fre-
quent and more persistent than those experienced in any of the other
sensory modalities (Goodwin et al., 1971), MMHs may be missed by
studies that focus exclusively on their present-state occurrence. This
also holds true for clinical practice, in which the focus tends to lie
quite exclusively on present-state symptoms. Altogether, these obser-
vationsmay also explainwhyour analysis failed to replicate the ﬁndings
from earlier transcultural studies showing that MMHs seemmore prev-
alent in non-Western than in Western patient groups diagnosed with a
schizophrenia spectrum disorder.
Fig. 2. Schematic diagram showing the one month distribution of unimodal and multimodal hallucinations among 285 patients from 750 patients diagnosed with a schizophrenia
spectrum disorder.
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The high prevalence rate of MMHs found in our patient group as a
whole is all the more remarkable when considering that the CASH al-
lows to chart hallucinations experienced in four sensory modalities
(i.e., auditory, visual, olfactory, and somatic/tactile), whereas some clas-
siﬁcations distinguish up to 14 sensory modalities (Gibson, 1966; Blom,
2013) and equally many main groups of hallucinations (Table 3). In
Table 3, although the category ‘somatic/tactile’ is split into two separate
categories (with tactile hallucinations referring to hallucinations of
touch, and somatic ones to hallucinations experienced inside theTable 3
Sensory modalities and corresponding unimodal types of hallucination.
Adapted from Blom (2013).
Sensory modality Type of hallucination
1. Visual modality Visual hallucination
2. Auditory modality Auditory (acoustic) hallucination
3. Olfactory modality Olfactory hallucination
4. Gustatory modality Gustatory hallucination
5. Exteroceptive modality Tactile (haptic) hallucination
6. Interoceptive modality Somatic hallucination
7. Proprioceptive modality Proprioceptive hallucination
8. Kinesthetic modality Kinesthetic hallucination
9. Vestibular modality Vestibular hallucination
10. Cenesthetic modality Cenesthetic hallucination
11. Pain modality Algesic hallucination (hallucinated pain, central pain)
12. Sexual modality Sexual hallucination
13. Temperature modality Thermal (thermic) hallucination
14. Temporal modality Time distortionbody), it still leaves nine more types of unimodal hallucination that
can be explored. Many of those types have not yet been systematically
studied and still have unknown prevalence rates; however, even if
these rates prove to be low, the prevalence rate of MMHs found in the
present study may be considered a conservative estimate of the actual
rate.
Another important ﬁnding from our analysis is that the number of
patients reportingMMHs in three or four sensory modalities is relative-
ly high. Although the GROUP data do not allow for a reconstruction of
the temporal order in which various unimodal hallucinations add up
toMMHs, this suggests that the threshold for developing auditory hallu-
cinations in this group is relatively low (given their high distribution
rate) and that, in turn, the presence of auditory hallucinations lowers
the threshold for developing any additional types of hallucination, nota-
bly visual ones. When hallucinations are present in these two sensory
modalities, the chance for even more sensory modalities to become in-
volved seems to increase further. This peculiar stochastic process was
noted as early as 1900 by Störring, whose observations prompted him
to remark that when one sensory modality is involved in hallucinatory
activity, another one may easily join in (Störring, 1900). This process
was also mentioned by David et al. (2011), who speak of “an additive
progression of hallucination categories in order of descending frequen-
cy” to explain the considerable overall overlap between various types of
hallucination, and the ﬁnding that somatic/tactile and olfactory halluci-
nations did not appear in their subjects without the appearance of hal-
lucinations in the auditory and visual modalities. We speculate that the
networks involved in the mediation of verbal auditory hallucinations
may serve as hubs in the perceptual network which promote the re-
cruitment of subsequent sensory modalities to mediate MMHs
(Looijestijn et al., 2015).
498 A. Lim et al. / Schizophrenia Research 176 (2016) 493–4994.2. Nomenclature and classiﬁcation
An issue that cannot be solved on the basis of our data, is whether
theMMHs, as reported by the participants of theGROUP study, combine
to constitute compound hallucinations, or even whether they are expe-
rienced serially or simultaneously. In the literature, MMHs are some-
times designated in terms of combinations of the sensory modalities
involved, e.g. audiovisual hallucination, audioalgesic hallucination, and
so on (Jacome and Gumnit, 1979). Terms such as these have the advan-
tage of describing the sensory modalities involved, but fail to indicate
whether the hallucinations in these sensory modalities are experienced
simultaneously or serially. As noted previously (Chesterman and Boast,
1994), the literature on MMHs suffers from a lack of information on
these phenomenological characteristics, and even from the lack of a pre-
cise nomenclature with which to address this problem. A proper no-
menclature of MMHs should allow us to identify the exact number
and nature of the sensory modalities involved, to differentiate between
hallucinations in various sensory modalities which are experienced se-
rially or simultaneously, and, in the latter case, to differentiate between
incongruent and congruent (i.e., compound) ones. Here, the adjective
‘incongruent’ refers to phenomena such as a visually hallucinated face
experienced simultaneously with the sound of a barking dog, and the
adjective ‘congruent’ refers to a visually hallucinated face that is seen
talking, with verbal auditory hallucinations to match. Table 4 presents
a classiﬁcation of MMHs that allows for such a uniform and systematic
characterization of MMHs, provided that the sensory modalities in-
volved are also carefully listed.
4.3. Pathophysiology
Apart from its clinical usefulness, a proper nomenclature of MMHs is
also a prerequisite for studies on the pathophysiology of MMHs. Sys-
tematic studies in this area are lacking, and even case reports are rare.
In his 1914 book chapter, Specht posed the cardinal question: whether
MMHs are mediated by various sensory brain areas showing separate
but simultaneous hallucinatory activity, or by a single higher integrative
center (Störring, 1900). As recently indicated by ffytche and Wible
(2014), that question has gone unanswered throughout the intervening
century and is evenmore pressing today than it was then. Classical cor-
tical probing experiments, such as those performed by Penﬁeld, suggest
that MMHs (notably perceptions that take the form of panoramic hallu-
cinations) may be mediated by circumscript brain areas in relative iso-
lation (Penﬁeld and Perot, 1963), whereas Liddle et al. (2000)
consider the left hippocampus, ventral striatum, and variousTable 4
Classiﬁcation of unimodal and multimodal hallucinations.
Type of hallucination Characterization
Unimodal hallucination Hallucination experienced in a single sensory
modality
Multimodal hallucination Hallucinations experienced in two or more
sensory modalities
Serial multimodal hallucination Hallucinations experienced in two or more
sensory modalities at different moments in
time
Simultaneous multimodal
hallucination
Hallucinations experienced in two or more
sensory modalities simultaneously
Incongruent multimodal
hallucination
Hallucinations experienced in two or more
sensory modalities simultaneously which do
not add up to a coherent whole
Congruent multimodal
hallucination (compound
hallucination)
Hallucinations experienced in two or more
sensory modalities simultaneously which add
up to a coherent wholedisseminated cortico-striato-thalamic feedback loops to be responsible
for their mediation. With the aid of functional magnetic resonance im-
aging (fMRI) and other imaging techniques it is now possible to test hy-
potheses such as these, in a way similar to themany studies that helped
to chart the neuropathological correlates of verbal auditory hallucina-
tions over thepast decade (Blom, 2015). However, the success of studies
such as these relies on the adequate coupling of activation maps and
phenomenological descriptions as outlined above, including the use of
a uniform nomenclature.4.4. Limitations
As in previous studies on MMHs, the present study has several limi-
tations. First, the number of sensory modalities under study comprised
only four (or ﬁve, if we take tactile and somatic as separate sensorymo-
dalities) whereas some authors distinguish up to 14 sensorymodalities.
Secondly, the CASH was designed to probe the (lifetime) presence of
hallucinations in these four sensory modalities without attempting to
reconstruct the temporal order in which they are experienced, and
without addressing the questionswhether they are experienced serially
or simultaneously and whether they are congruent or incongruent in
nature. As a result, these questions remain unanswered in the present
study. Thirdly, the GROUP study excluded patients who were insufﬁ-
ciently ﬂuent in Dutch, but whose inclusion might have yielded a larger
proportion of migrants and, hence, a shift in the prevalence rates of
MMHs as found in our study. Fourth, women with schizophrenia spec-
trum disorders are underrepresented. Last but not least, our study
does not allow to answer the question from previous studies, as to
whether MMHs are indicative of any underlying organic etiology.
Starting from the general premise that hallucinations are mediated by
the perceptual system, their etiology may be considered invariably or-
ganic in nature. Nevertheless, whether or not MMHs are more often as-
sociated with non-psychiatric etiologies, such as epilepsy or
demonstrable intracranial lesions, remains unknown.4.5. Conclusion and recommendations
Multimodal hallucinations (MMHs) are twice as prevalent in pa-
tients diagnosedwith a schizophrenia spectrumdisorder thanunimodal
ones. Based on the present study we conclude that MMHs, rather than
auditory hallucinations, are a characteristic feature of this patient
group and that hallucinations experienced in a single sensory modality
stochastically increase the chance of more sensory modalities to join in.
Future studies need to assess the full range of sensory modalities in
which hallucinations can be experienced; these studies need to careful-
ly reconstruct i) the temporal order in which these modalities become
involved, ii) whether the hallucinations are experienced serially or si-
multaneously, and iii)whether they are congruent or incongruent in na-
ture. Such analyses of the phenomenology together with research on
the prognostic value of MMHsmay further elucidate these phenomena.
To facilitate this process, we recommend the development of dedicated
measurement tools that address all three issues mentioned above.Conﬂict of interest
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